Dear Colleague:
I am pleased to announce production of CHI’s 3rd Annual Electronic Data in Clinical Trials: Collecting and Leveraging Data to Optimize Clinical Trials, being held February 7-8, 2011 at the Westin Colonnade Coral Gables in Miami, FL.
The gathering will once again be co-located with the Summit for Clinical Trials Operations Executives (SCOPE), a three-day cluster of events that attracted over 300 leaders in clinical operations and research in March 2010. Please see the program map below for 2011.
New technology is available and being created everyday to make the collection, correction and assessment of data from clinical trials more efficient. How do you decide which to use and when to use it? What are the common problems with implementation and how do you resolve them? Topics to be discussed:
Utilization of Electronic Health Record (EHR) data in clinical research: Overcoming regulatory, policy, technical and organizational challenges
Approaching data integration for BioTech, Small/Midsize Pharma and Big Pharma: Integrating systems (EDC, IVRS, CTMS) and clinical operations data
Increasing clinical trial efficiency through operational data management: Best practices in integrating safety reporting data and your EDC system
Incorporating and integrating the eClinical systems and practices of two organizations: Lessons learned in the latest set of mergers
Electronic Data Capture (EDC) adoption: Changes in processes and procedures and training staff (sponsor staff, site, CROs)
Available technologies and vendor selection: Selecting the right partner for your strategy
Regulatory compliance issues on the use of computerized systems in clinical investigations: Qualification of sites that have EMR/HER systems for source documents; Regulatory audits at sites using EDC
Integration of mobile and web-based technologies to enable the patient-centered clinical trial
Leveraging technology to enable adaptive trials: Is EDC an absolute necessity?
E-Diaries: Ease of use and compliance in various populations and consistency of data with data previously collected by paper diaries
Information security and EDC: Safeguarding the security and reliability of Electronic Clinical Trials (ECT)
Practical implementation of CDASH recommendations
If you are interested in presenting, please click here to submit a speaking proposal for review. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academic/hospital centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
The deadline for submission is July 2, 2010.
For Further Information
For questions or suggestions about the meeting, please contact:
Micah Lieberman
Executive Director, Conferences
Pharmaceutical Strategy Series
Cambridge Healthtech Institute (CHI)
Phone: (+1) 541.482.4709
Email: mlieberman@healthtech.com
For partnering and sponsorship information, please contact:
Arnie Wolfson
Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5431
Email: awolfson@healthtech.com
For media and association partnerships, please contact:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5456
Email: rhandy@healthtech.com
About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (CHI) (www.chicorporate.com) is the industry leader offering the preeminent source of information to the leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Events, Pharmaceutical Strategy Series, Barnett International, Insight Pharma Reports, Marketing Services, and Cambridge Healthtech Media Group.